Results 131 to 140 of about 6,662 (210)

Erratum: CXCR7 promotes pulmonary vascular remodeling via targeting p38/MMP2 pathway in pulmonary arterial hypertension. [PDF]

J Thorac Dis
Editorial Office.
europepmc   +1 more source

Epigenetic dysregulation and biological function of PDX1 in prostate cancer. [PDF]

Oncotarget
Adeyika TA, Datturgi A, Ettinoffe Y, Ghosh S, Albanese C, Kwabi-Addo B.   +5 more
europepmc   +1 more source

G protein-coupled receptors in prostate cancer: research progress and therapeutic targets. [PDF]

Front Cell Dev Biol
Xiong W, Zhou B, Shi J, Ni D, Xiong Z.
europepmc   +1 more source

Enhanced MIF/CD74 axis activity shapes B cell functioning following traumatic spinal cord injury. [PDF]

J Neuroinflammation
Rubio S, Beckers L, Coenen H, van Laake-Geelen CCM, Depreitere B, Bamps S, Cornips EMJ, Buelens E, Peuskens D, Deckers J, Somers V, Fraussen J.   +11 more
europepmc   +1 more source

Increased reactive astrocytes in hippocampal CA1 region mediated by decreased CXCR7 is involved in postoperative cognitive dysfunction in aged mice. [PDF]

Cell Biol Toxicol
Liu Q, Zhou CR, Wang HB, Liu YP, Dong W, Wan J, Miao HH, Zhou CH, Wu YQ.   +8 more
europepmc   +1 more source

C-X-C chemokine receptor family genes in osteosarcoma: expression profiles, regulatory networks, and functional impact on tumor progression. [PDF]

Hereditas
Dong S, Xu H, Kong X, Bai Y, Hou X, Liu F, Xu Y.   +6 more
europepmc   +1 more source

Immunomodulatory crosstalk between GPCR and hippo signaling in cancer: implications for tumor immunity and therapeutic targeting. [PDF]

Front Immunol
Ren X, Xie T, Liu L, Jin X, Zhang M.
europepmc   +1 more source

Editorial: Community series in immune responses against tumors - from the bench to the bedside, volume II. [PDF]

Front Immunol
Wang CJ, Bao S.
europepmc   +1 more source

The CXCL12/CXCR4 Axis in Sepsis-Induced Acute Lung Injury: Mechanisms and Therapeutic Potential. [PDF]

Curr Issues Mol Biol
Luo R, Fan Q, Chen Q, Nie Z, Dan L, Xie S.   +5 more
europepmc   +1 more source

CXCR4-targeted therapy in lung cancer: plerixafor as a promising antimetastatic agent. [PDF]

Front Pharmacol
Ramalingam PS, Afzal M, Babu MA, Rekha MM, Sahoo S, Pandey SN, Goyal K, Hussain MS, Gupta G, Balakrishnan P, Arumugam S.   +10 more
europepmc   +1 more source